Research Library — Page 55 | Reta Compare
3563 research articles. Page 55 of 143.
Articles
- Exploring Retatrutide's Role in Weight Management and Primary Care Insights
- Exploring the Role of Retatrutide in Managing Rare Genetic Obesity in Youth
- Exploring Retatrutide: Advances in Peptide Therapies for Obesity and Diabetes
- Retatrutide: Insights into the Efficacy of Triple Agonists in Obesity Management
- Exploring Retatrutide: A Promising Agent in the Fight Against Obesity
- Exploring Retatrutide's Role in Obesity Treatment through GLP-1 Receptor Binding
- Exploring Retatrutide: Insights from Recent Advances in Obesity Pharmacotherapy
- Exploring Retatrutide: Insights from ObesityWeek 2023 on Weight-Loss Medications
- Retatrutide's Role in Treating NAFLD and MASLD: Insights from Recent Research
- Exploring the Role of Retatrutide in Diabetes and Obesity Management
- Retatrutide: A Potential New Treatment for Obesity and Type 2 Diabetes
- Exploring Retatrutide: A Triple Agonist in Obesity Management and Cardiovascular Safety
- Exploring Retatrutide: A Triple-Hormone-Receptor Agonist for Obesity Management
- Exploring the Role of Retatrutide as a Triple-Hormone-Receptor Agonist for Obesity Management
- Exploring the Role of Retatrutide as a Triple-Hormone-Receptor Agonist in Obesity Treatment
- Exploring the Role of Retatrutide in Triple Hormone Receptor Activation
- Retatrutide's Impact on Gastric Emptying: Insights from Recent Research
- Retatrutide Shows Promising Efficacy in Type 2 Diabetes Management
- Retatrutide's Efficacy in Weight Loss: Insights from a Phase 2 Trial
- Retatrutide Shows Significant Weight Loss in Triple-Hormone Combination Therapy
- Understanding Adipocyte Differentiation and Lipolytic Function in Retatrutide Research
- Exploring Retatrutide: A New Approach to Diabetes and Obesity Treatment
- Exploring the Role of Enteroendocrine Cells in Retatrutide Mechanisms
- Retatrutide: Insights from the Phase 1b Trial of LY3437943 in Type 2 Diabetes
- Exploring Retatrutide: Insights from LY3437943 as a Triple Agonist for Metabolic Health